| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.37e-09 | 4 | 15 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.85e-09 | 6 | 15 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.78e-07 | 18 | 15 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.52e-06 | 31 | 15 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.85e-06 | 33 | 15 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.13e-04 | 129 | 15 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.44e-04 | 140 | 15 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.80e-04 | 151 | 15 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.71e-04 | 193 | 15 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.94e-04 | 197 | 15 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.20e-04 | 230 | 15 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.82e-03 | 334 | 15 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.93e-03 | 749 | 15 | 4 | GO:0005509 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.96e-03 | 343 | 15 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.47e-03 | 459 | 15 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.63e-03 | 465 | 15 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 6.50e-03 | 525 | 15 | 3 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.53e-03 | 526 | 15 | 3 | GO:0022803 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 7.84e-03 | 562 | 15 | 3 | GO:0003712 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.06e-02 | 627 | 15 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.24e-02 | 664 | 15 | 3 | GO:0008324 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.25e-02 | 229 | 15 | 2 | GO:0140993 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 6.30e-08 | 11 | 16 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.39e-07 | 14 | 16 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | response to caffeine | 5.05e-07 | 21 | 16 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.93e-06 | 37 | 16 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.44e-06 | 39 | 16 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 3.72e-06 | 40 | 16 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 4.97e-06 | 44 | 16 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 1.15e-04 | 125 | 16 | 3 | GO:0043279 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 1.17e-04 | 21 | 16 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.67e-04 | 25 | 16 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 1.67e-04 | 25 | 16 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.82e-04 | 146 | 16 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.86e-04 | 147 | 16 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.93e-04 | 149 | 16 | 3 | GO:0051282 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.03e-04 | 396 | 16 | 4 | GO:0051235 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 2.09e-04 | 153 | 16 | 3 | GO:0051208 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.43e-04 | 161 | 16 | 3 | GO:0051592 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.65e-04 | 166 | 16 | 3 | GO:0014074 | |
| GeneOntologyBiologicalProcess | response to ATP | 4.33e-04 | 40 | 16 | 2 | GO:0033198 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 5.27e-04 | 509 | 16 | 4 | GO:0006816 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 5.81e-04 | 217 | 16 | 3 | GO:0006941 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 5.81e-04 | 217 | 16 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | ossification | 7.64e-04 | 562 | 16 | 4 | GO:0001503 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 9.71e-04 | 259 | 16 | 3 | GO:0051651 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 1.05e-03 | 266 | 16 | 3 | GO:0019722 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.12e-03 | 622 | 16 | 4 | GO:0098771 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.60e-03 | 77 | 16 | 2 | GO:0051289 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.77e-03 | 705 | 16 | 4 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.89e-03 | 717 | 16 | 4 | GO:0050801 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.90e-03 | 84 | 16 | 2 | GO:0051480 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 2.01e-03 | 1249 | 16 | 5 | GO:0048878 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 2.08e-03 | 88 | 16 | 2 | GO:0071277 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 2.47e-03 | 359 | 16 | 3 | GO:0006874 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 3.11e-03 | 389 | 16 | 3 | GO:0055074 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 3.17e-03 | 392 | 16 | 3 | GO:0070588 | |
| GeneOntologyBiologicalProcess | muscle contraction | 3.36e-03 | 400 | 16 | 3 | GO:0006936 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.40e-03 | 113 | 16 | 2 | GO:0051262 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 3.57e-03 | 116 | 16 | 2 | GO:0008344 | |
| GeneOntologyBiologicalProcess | response to metal ion | 3.73e-03 | 415 | 16 | 3 | GO:0010038 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 5.12e-06 | 45 | 16 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 5.47e-06 | 46 | 16 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.97e-05 | 9 | 16 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.21e-05 | 73 | 16 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.46e-05 | 10 | 16 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.88e-05 | 88 | 16 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 8.40e-05 | 114 | 16 | 3 | GO:0016528 | |
| GeneOntologyCellularComponent | Z disc | 1.93e-04 | 151 | 16 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 2.55e-04 | 166 | 16 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.51e-04 | 185 | 16 | 3 | GO:0009898 | |
| GeneOntologyCellularComponent | sarcolemma | 3.79e-04 | 190 | 16 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 6.62e-04 | 230 | 16 | 3 | GO:0098562 | |
| GeneOntologyCellularComponent | cation channel complex | 7.05e-04 | 235 | 16 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 8.26e-04 | 56 | 16 | 2 | GO:0031234 | |
| GeneOntologyCellularComponent | sarcomere | 8.34e-04 | 249 | 16 | 3 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.09e-03 | 273 | 16 | 3 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.29e-03 | 290 | 16 | 3 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.46e-03 | 1179 | 16 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.51e-03 | 1187 | 16 | 5 | GO:0099081 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.76e-03 | 378 | 16 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 4.82e-03 | 137 | 16 | 2 | GO:0019897 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 6.84e-03 | 523 | 16 | 3 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 7.86e-03 | 550 | 16 | 3 | GO:1990351 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.31e-02 | 230 | 16 | 2 | GO:0019898 | |
| MousePheno | decreased body length | 6.41e-06 | 484 | 15 | 6 | MP:0001258 | |
| MousePheno | abnormal body length | 1.33e-05 | 550 | 15 | 6 | MP:0001256 | |
| MousePheno | abnormal paired-pulse ratio | 2.25e-05 | 7 | 15 | 2 | MP:0014252 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 2.68e-04 | 23 | 15 | 2 | MP:0004088 | |
| Domain | RR_TM4-6 | 4.19e-10 | 3 | 15 | 3 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 4.19e-10 | 3 | 15 | 3 | IPR009460 | |
| Domain | RyR | 4.19e-10 | 3 | 15 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 4.19e-10 | 3 | 15 | 3 | IPR003032 | |
| Domain | Ryan_recept | 4.19e-10 | 3 | 15 | 3 | IPR013333 | |
| Domain | RIH_assoc | 8.37e-09 | 6 | 15 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 8.37e-09 | 6 | 15 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.37e-09 | 6 | 15 | 3 | PF08709 | |
| Domain | RYDR_ITPR | 8.37e-09 | 6 | 15 | 3 | PF01365 | |
| Domain | RIH_dom | 8.37e-09 | 6 | 15 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.37e-09 | 6 | 15 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.37e-09 | 6 | 15 | 3 | IPR015925 | |
| Domain | - | 8.37e-09 | 6 | 15 | 3 | 1.25.10.30 | |
| Domain | MIR | 5.01e-08 | 10 | 15 | 3 | PS50919 | |
| Domain | MIR | 5.01e-08 | 10 | 15 | 3 | PF02815 | |
| Domain | MIR | 5.01e-08 | 10 | 15 | 3 | SM00472 | |
| Domain | MIR_motif | 5.01e-08 | 10 | 15 | 3 | IPR016093 | |
| Domain | SPRY | 4.27e-05 | 87 | 15 | 3 | SM00449 | |
| Domain | SPRY | 5.38e-05 | 94 | 15 | 3 | PF00622 | |
| Domain | SPRY_dom | 5.38e-05 | 94 | 15 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 5.55e-05 | 95 | 15 | 3 | IPR001870 | |
| Domain | B302_SPRY | 5.55e-05 | 95 | 15 | 3 | PS50188 | |
| Domain | EF-hand-dom_pair | 6.52e-05 | 287 | 15 | 4 | IPR011992 | |
| Domain | Ion_trans_dom | 9.55e-05 | 114 | 15 | 3 | IPR005821 | |
| Domain | Ion_trans | 9.55e-05 | 114 | 15 | 3 | PF00520 | |
| Domain | EF-hand_8 | 3.33e-04 | 34 | 15 | 2 | PF13833 | |
| Domain | ConA-like_dom | 6.52e-04 | 219 | 15 | 3 | IPR013320 | |
| Domain | EF_hand_dom | 7.71e-04 | 232 | 15 | 3 | IPR002048 | |
| Domain | - | 1.08e-03 | 261 | 15 | 3 | 1.10.238.10 | |
| Domain | PHD | 1.62e-03 | 75 | 15 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 1.79e-03 | 79 | 15 | 2 | IPR019787 | |
| Domain | PHD | 2.26e-03 | 89 | 15 | 2 | SM00249 | |
| Domain | Znf_PHD | 2.37e-03 | 91 | 15 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.57e-03 | 95 | 15 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 2.63e-03 | 96 | 15 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 6.04e-03 | 147 | 15 | 2 | IPR011011 | |
| Domain | EF-hand_1 | 6.44e-03 | 152 | 15 | 2 | PF00036 | |
| Domain | EF_HAND_2 | 1.44e-02 | 231 | 15 | 2 | PS50222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.01e-07 | 11 | 13 | 3 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.74e-07 | 13 | 13 | 3 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.89e-07 | 19 | 13 | 3 | M47760 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.48e-05 | 54 | 13 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.48e-05 | 54 | 13 | 3 | MM15202 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 9.13e-05 | 99 | 13 | 3 | MM14910 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.03e-04 | 103 | 13 | 3 | MM15196 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.12e-04 | 106 | 13 | 3 | M27200 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.05e-04 | 130 | 13 | 3 | M27454 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.94e-04 | 147 | 13 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.18e-04 | 151 | 13 | 3 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.37e-04 | 154 | 13 | 3 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.50e-04 | 156 | 13 | 3 | M39475 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.13e-04 | 165 | 13 | 3 | MM15026 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.99e-04 | 176 | 13 | 3 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.16e-04 | 178 | 13 | 3 | M2890 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.59e-04 | 183 | 13 | 3 | M997 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.56e-04 | 203 | 13 | 3 | M5485 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 7.94e-04 | 46 | 13 | 2 | M48105 | |
| Pathway | WP_GPCRS_ODORANT | 8.87e-03 | 157 | 13 | 2 | MM15872 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 7.99e-11 | 3 | 16 | 3 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 7.99e-11 | 3 | 16 | 3 | 9204703 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18643873 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 11159936 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 7876312 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 9242641 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18403125 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 21881589 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 7.99e-11 | 3 | 16 | 3 | 10788707 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18434746 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 7.99e-11 | 3 | 16 | 3 | 10473538 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 7959768 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 7.99e-11 | 3 | 16 | 3 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 7.99e-11 | 3 | 16 | 3 | 4600883 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 7635066 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 9384575 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 18206662 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 9607712 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 23482488 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.19e-10 | 4 | 16 | 3 | 23413940 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 7.98e-10 | 5 | 16 | 3 | 19011160 | |
| Pubmed | 7.98e-10 | 5 | 16 | 3 | 23918386 | ||
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 19549818 | ||
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.60e-09 | 6 | 16 | 3 | 16844763 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.60e-09 | 6 | 16 | 3 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 1.60e-09 | 6 | 16 | 3 | 14592808 | |
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 23463619 | ||
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.60e-09 | 6 | 16 | 3 | 25966694 | |
| Pubmed | 2.79e-09 | 7 | 16 | 3 | 20962236 | ||
| Pubmed | 2.79e-09 | 7 | 16 | 3 | 11860456 | ||
| Pubmed | 4.47e-09 | 8 | 16 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.47e-09 | 8 | 16 | 3 | 19033399 | |
| Pubmed | 1.75e-08 | 12 | 16 | 3 | 19095005 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 12565913 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 9489997 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.98e-07 | 2 | 16 | 2 | 15894801 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 9192302 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 30542613 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 1.98e-07 | 2 | 16 | 2 | 25370123 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.98e-07 | 2 | 16 | 2 | 12640042 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 14985349 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 14550562 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.98e-07 | 2 | 16 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.98e-07 | 2 | 16 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.98e-07 | 2 | 16 | 2 | 26009179 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 1.98e-07 | 2 | 16 | 2 | 11673493 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 11673462 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 7556644 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 1.98e-07 | 2 | 16 | 2 | 18618700 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.98e-07 | 2 | 16 | 2 | 21531043 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 32899693 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 14592949 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 9799464 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 16678258 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.98e-07 | 2 | 16 | 2 | 17118445 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 9817784 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 8898078 | ||
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.98e-07 | 2 | 16 | 2 | 11500519 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 23278119 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 11171121 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 5.95e-07 | 3 | 16 | 2 | 9986730 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 24123915 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 18313230 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 5.95e-07 | 3 | 16 | 2 | 23454728 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 5.95e-07 | 3 | 16 | 2 | 15024040 | |
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 5.95e-07 | 3 | 16 | 2 | 29730765 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.67e-07 | 38 | 16 | 3 | 30786075 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 22100703 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 19120137 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 22504960 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 1.19e-06 | 4 | 16 | 2 | 11237759 | |
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 1.19e-06 | 4 | 16 | 2 | 23992453 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 27226555 | ||
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 1.98e-06 | 5 | 16 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 1.98e-06 | 5 | 16 | 2 | 9124414 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 33060591 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 10444070 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 5.55e-06 | 8 | 16 | 2 | 30563862 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 21441923 | ||
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 21858002 | ||
| Pubmed | 8.91e-06 | 10 | 16 | 2 | 18434328 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 1.80e-05 | 14 | 16 | 2 | 28724790 | |
| Pubmed | 3.66e-05 | 143 | 16 | 3 | 20424473 | ||
| Pubmed | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. | 1.38e-04 | 38 | 16 | 2 | 26134413 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.28e-04 | 265 | 16 | 3 | 19240061 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.78e-04 | 724 | 16 | 4 | 36232890 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 3.12e-04 | 57 | 16 | 2 | 23788249 | |
| Pubmed | 3.57e-04 | 61 | 16 | 2 | 20305087 | ||
| Interaction | RYR2 interactions | 1.23e-05 | 58 | 16 | 3 | int:RYR2 | |
| Interaction | AKAP6 interactions | 7.98e-05 | 17 | 16 | 2 | int:AKAP6 | |
| Interaction | SP7 interactions | 8.01e-05 | 304 | 16 | 4 | int:SP7 | |
| Interaction | RYR3 interactions | 1.61e-04 | 24 | 16 | 2 | int:RYR3 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.90e-10 | 3 | 13 | 3 | 287 | |
| GeneFamily | PHD finger proteins | 1.84e-03 | 90 | 13 | 2 | 88 | |
| GeneFamily | EF-hand domain containing | 1.04e-02 | 219 | 13 | 2 | 863 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.31e-04 | 166 | 16 | 3 | M39026 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.44e-04 | 171 | 16 | 3 | M39234 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 2.28e-04 | 200 | 16 | 3 | M7478 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 2.28e-04 | 200 | 16 | 3 | M7978 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN | 2.28e-04 | 200 | 16 | 3 | M8602 | |
| Coexpression | GSE2585_CTEC_VS_MTEC_THYMUS_UP | 2.28e-04 | 200 | 16 | 3 | M6265 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 2.28e-04 | 200 | 16 | 3 | M5956 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 2.55e-04 | 39 | 16 | 2 | M13339 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.82e-05 | 219 | 16 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_200 | 2.92e-05 | 11 | 16 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 1.11e-04 | 21 | 16 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.01e-04 | 776 | 16 | 5 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 2.25e-04 | 795 | 16 | 5 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.04e-04 | 179 | 16 | 3 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 160 | 16 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 160 | 16 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 166 | 16 | 3 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 166 | 16 | 3 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 176 | 16 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 183 | 16 | 3 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 184 | 16 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 184 | 16 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 184 | 16 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.68e-05 | 185 | 16 | 3 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.92e-05 | 189 | 16 | 3 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.64e-05 | 200 | 16 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.64e-05 | 200 | 16 | 3 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.46e-04 | 88 | 16 | 2 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.46e-04 | 88 | 16 | 2 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.46e-04 | 88 | 16 | 2 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 8.82e-04 | 124 | 16 | 2 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.10e-04 | 126 | 16 | 2 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.24e-04 | 127 | 16 | 2 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-04 | 128 | 16 | 2 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-04 | 130 | 16 | 2 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 9.83e-04 | 131 | 16 | 2 | ae5eb9c013674b36987bf26d4f752dbb374f547b | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.98e-04 | 132 | 16 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 134 | 16 | 2 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-03 | 136 | 16 | 2 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-03 | 136 | 16 | 2 | a2063abe2d7c3277bfbe1514c8c66363cf04b248 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 137 | 16 | 2 | 8e2fa2ef8becace96a68bb85c002329110902fbb | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-03 | 140 | 16 | 2 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-03 | 144 | 16 | 2 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.22e-03 | 146 | 16 | 2 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-03 | 148 | 16 | 2 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-03 | 148 | 16 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 1.32e-03 | 152 | 16 | 2 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.34e-03 | 153 | 16 | 2 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-03 | 154 | 16 | 2 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.35e-03 | 154 | 16 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 157 | 16 | 2 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-03 | 157 | 16 | 2 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 157 | 16 | 2 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.42e-03 | 158 | 16 | 2 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.42e-03 | 158 | 16 | 2 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.42e-03 | 158 | 16 | 2 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-03 | 159 | 16 | 2 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.44e-03 | 159 | 16 | 2 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-03 | 159 | 16 | 2 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-03 | 159 | 16 | 2 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-03 | 159 | 16 | 2 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-03 | 160 | 16 | 2 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-03 | 160 | 16 | 2 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.48e-03 | 161 | 16 | 2 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.48e-03 | 161 | 16 | 2 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-03 | 163 | 16 | 2 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.53e-03 | 164 | 16 | 2 | 08c725548e751f815b4df778607270498204b353 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.53e-03 | 164 | 16 | 2 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-03 | 164 | 16 | 2 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-03 | 164 | 16 | 2 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-03 | 165 | 16 | 2 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.55e-03 | 165 | 16 | 2 | ecaeb90a6bc27524ef6f2eefa72aec7315dbde3b | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-03 | 167 | 16 | 2 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.59e-03 | 167 | 16 | 2 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-03 | 169 | 16 | 2 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-03 | 169 | 16 | 2 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 169 | 16 | 2 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-03 | 170 | 16 | 2 | 021c3e45955d18e241f7d98acdf22076fee4fc43 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-03 | 170 | 16 | 2 | 17b8c53c69d78d1b343a5f86d4f82896deee1b0d | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-03 | 171 | 16 | 2 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-03 | 172 | 16 | 2 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.70e-03 | 173 | 16 | 2 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 173 | 16 | 2 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 173 | 16 | 2 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-03 | 174 | 16 | 2 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.72e-03 | 174 | 16 | 2 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-03 | 174 | 16 | 2 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-03 | 174 | 16 | 2 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-03 | 174 | 16 | 2 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-03 | 174 | 16 | 2 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.74e-03 | 175 | 16 | 2 | 4b77e9cf712c9e3b4fb68462a96aea47be124e8d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-03 | 175 | 16 | 2 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 176 | 16 | 2 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-03 | 176 | 16 | 2 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.76e-03 | 176 | 16 | 2 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.76e-03 | 176 | 16 | 2 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-03 | 176 | 16 | 2 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-03 | 176 | 16 | 2 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 176 | 16 | 2 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-03 | 177 | 16 | 2 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-03 | 177 | 16 | 2 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-03 | 177 | 16 | 2 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-03 | 178 | 16 | 2 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.80e-03 | 178 | 16 | 2 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-03 | 179 | 16 | 2 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-03 | 179 | 16 | 2 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.82e-03 | 179 | 16 | 2 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-03 | 179 | 16 | 2 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-03 | 180 | 16 | 2 | a499548391e6833b78f6e920f8e32a755814a9da | |
| Computational | Neighborhood of MAGEA8 | 2.01e-04 | 260 | 13 | 4 | MORF_MAGEA8 | |
| Computational | Neighborhood of FSHR | 2.64e-04 | 279 | 13 | 4 | MORF_FSHR | |
| Computational | Neighborhood of CAMK4 | 3.06e-04 | 290 | 13 | 4 | MORF_CAMK4 | |
| Computational | Neighborhood of SUPT3H | 4.89e-04 | 328 | 13 | 4 | MORF_SUPT3H | |
| Computational | Neighborhood of RAD51L3 | 9.13e-04 | 387 | 13 | 4 | MORF_RAD51L3 | |
| Computational | Neighborhood of DMPK | 1.08e-03 | 175 | 13 | 3 | MORF_DMPK | |
| Computational | Neighborhood of PRKCA | 1.19e-03 | 181 | 13 | 3 | MORF_PRKCA | |
| Computational | Neighborhood of MAP2K7 | 1.19e-03 | 181 | 13 | 3 | MORF_MAP2K7 | |
| Computational | Neighborhood of BCL2L11 | 1.28e-03 | 186 | 13 | 3 | MORF_BCL2L11 | |
| Computational | Neighborhood of CTSB | 1.30e-03 | 187 | 13 | 3 | MORF_CTSB | |
| Computational | Neighborhood of IL4 | 1.41e-03 | 192 | 13 | 3 | MORF_IL4 | |
| Computational | Neighborhood of IFNA1 | 1.70e-03 | 205 | 13 | 3 | MORF_IFNA1 | |
| Computational | Neighborhood of IL16 | 2.63e-03 | 239 | 13 | 3 | MORF_IL16 | |
| Computational | Ion channels. | 3.11e-03 | 70 | 13 | 2 | MODULE_316 | |
| Computational | Neighborhood of PTPRB | 3.13e-03 | 254 | 13 | 3 | MORF_PTPRB | |
| Computational | Neighborhood of MDM2 | 4.08e-03 | 279 | 13 | 3 | MORF_MDM2 | |
| Computational | Neighborhood of NOS2A | 4.46e-03 | 288 | 13 | 3 | MORF_NOS2A | |
| Computational | Neighborhood of PTEN | 4.56e-03 | 85 | 13 | 2 | MORF_PTEN | |
| Computational | Neighborhood of MLLT10 | 5.09e-03 | 302 | 13 | 3 | MORF_MLLT10 | |
| Computational | Neighborhood of ARL3 | 5.19e-03 | 304 | 13 | 3 | MORF_ARL3 | |
| Computational | Neighborhood of ERCC4 | 6.04e-03 | 321 | 13 | 3 | MORF_ERCC4 | |
| Computational | Neighborhood of PTPRR | 6.50e-03 | 102 | 13 | 2 | MORF_PTPRR | |
| Computational | Neighborhood of ATF2 | 6.52e-03 | 330 | 13 | 3 | MORF_ATF2 | |
| Drug | 2-hydroxyheptanoic acid | 2.85e-10 | 3 | 16 | 3 | CID002750949 | |
| Drug | 2-hydroxycarbazole | 2.85e-10 | 3 | 16 | 3 | CID000093551 | |
| Drug | aminodantrolene | 2.85e-10 | 3 | 16 | 3 | CID009570289 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.85e-10 | 3 | 16 | 3 | CID005748312 | |
| Drug | 8N3-cADPR | 2.85e-10 | 3 | 16 | 3 | CID000127713 | |
| Drug | cis-diammineplatinum(II | 2.85e-10 | 3 | 16 | 3 | CID000159790 | |
| Drug | AC1L1U7A | 1.14e-09 | 4 | 16 | 3 | CID000035682 | |
| Drug | PCB74 | 1.14e-09 | 4 | 16 | 3 | CID000036218 | |
| Drug | SC 38249 | 1.14e-09 | 4 | 16 | 3 | CID000134834 | |
| Drug | 148504-47-6 | 1.14e-09 | 4 | 16 | 3 | CID006444275 | |
| Drug | NSC114784 | 5.69e-09 | 6 | 16 | 3 | CID000419425 | |
| Drug | MBED | 5.69e-09 | 6 | 16 | 3 | CID000129958 | |
| Drug | AC1O528X | 5.69e-09 | 6 | 16 | 3 | CID006475857 | |
| Drug | chloro-m-cresol | 5.69e-09 | 6 | 16 | 3 | CID000012008 | |
| Drug | Azumoleno | 9.95e-09 | 7 | 16 | 3 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 9.95e-09 | 7 | 16 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 9.95e-09 | 7 | 16 | 3 | CID003081001 | |
| Drug | PCB 95 | 3.41e-08 | 10 | 16 | 3 | CID000038012 | |
| Drug | PCB 66 | 4.68e-08 | 11 | 16 | 3 | CID000036185 | |
| Drug | R 478 | 4.68e-08 | 11 | 16 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 4.68e-08 | 11 | 16 | 3 | CID003081323 | |
| Drug | Ryanodine | 6.24e-08 | 12 | 16 | 3 | ctd:D012433 | |
| Drug | FPL 64176 | 1.29e-07 | 15 | 16 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 1.29e-07 | 15 | 16 | 3 | CID000125015 | |
| Drug | kazinol B | 1.92e-07 | 17 | 16 | 3 | CID000480869 | |
| Drug | methylcoumarin | 2.31e-07 | 18 | 16 | 3 | CID000007092 | |
| Drug | AC1L380G | 2.74e-07 | 19 | 16 | 3 | CID000084698 | |
| Drug | AC1MW7VF | 2.74e-07 | 19 | 16 | 3 | CID000414699 | |
| Drug | indo-1/AM | 3.76e-07 | 21 | 16 | 3 | CID000123918 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.63e-07 | 2 | 16 | 2 | ctd:C005147 | |
| Drug | T0702 | 6.49e-07 | 25 | 16 | 3 | CID000005908 | |
| Drug | 2,4-xylidinothiazoline | 1.14e-06 | 30 | 16 | 3 | CID000099296 | |
| Drug | LOPAC | 1.14e-06 | 30 | 16 | 3 | CID000062696 | |
| Drug | M-HN | 1.26e-06 | 31 | 16 | 3 | CID000015450 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.39e-06 | 3 | 16 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.39e-06 | 3 | 16 | 2 | CID011193251 | |
| Drug | M3/M4 | 1.39e-06 | 32 | 16 | 3 | CID000486507 | |
| Drug | IHC-64 | 1.53e-06 | 33 | 16 | 3 | CID000162753 | |
| Drug | CNS 1145 | 1.53e-06 | 33 | 16 | 3 | CID000190902 | |
| Drug | AC1L1IZE | 1.81e-06 | 131 | 16 | 4 | CID000004799 | |
| Drug | mag-fura-2 | 2.18e-06 | 37 | 16 | 3 | CID000123839 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.18e-06 | 37 | 16 | 3 | CID000009643 | |
| Drug | 4-chloro-m-cresol | 2.18e-06 | 37 | 16 | 3 | CID000001732 | |
| Drug | AC1L98DX | 2.37e-06 | 38 | 16 | 3 | CID000439957 | |
| Drug | NAADP | 2.56e-06 | 39 | 16 | 3 | CID000123952 | |
| Drug | dipyrone | 2.77e-06 | 40 | 16 | 3 | CID000003110 | |
| Drug | A-30 | 2.78e-06 | 4 | 16 | 2 | CID003028528 | |
| Drug | Bastadin 10 | 2.78e-06 | 4 | 16 | 2 | CID009589366 | |
| Drug | Dantrolene | 2.99e-06 | 41 | 16 | 3 | ctd:D003620 | |
| Drug | lead compounds | 3.10e-06 | 150 | 16 | 4 | CID000073212 | |
| Drug | isocitrate | 3.62e-06 | 156 | 16 | 4 | CID000001198 | |
| Drug | escina | 3.71e-06 | 44 | 16 | 3 | CID006433489 | |
| Drug | 4,4'-dithiodipyridine | 3.97e-06 | 45 | 16 | 3 | CID000075846 | |
| Drug | A 68930 | 4.62e-06 | 5 | 16 | 2 | ctd:C065380 | |
| Drug | ts M | 4.83e-06 | 48 | 16 | 3 | CID000428025 | |
| Drug | Trp-Trp | 5.14e-06 | 49 | 16 | 3 | CID000088656 | |
| Drug | AC1L9KQO | 5.14e-06 | 49 | 16 | 3 | CID000447335 | |
| Drug | etridiazole | 5.47e-06 | 50 | 16 | 3 | CID000017432 | |
| Drug | NSC692750 | 6.93e-06 | 6 | 16 | 2 | CID000078910 | |
| Drug | Cinildipine | 7.72e-06 | 56 | 16 | 3 | CID000002752 | |
| Drug | cysteinylglycine | 8.14e-06 | 57 | 16 | 3 | CID000065270 | |
| Drug | NSC3260 | 8.76e-06 | 195 | 16 | 4 | CID000220461 | |
| Drug | nilvadipine | 9.51e-06 | 60 | 16 | 3 | CID000004494 | |
| Drug | mag-indo-1 | 9.70e-06 | 7 | 16 | 2 | CID000131881 | |
| Drug | CHEBI:564108 | 9.70e-06 | 7 | 16 | 2 | CID006400637 | |
| Drug | IAA-94 | 1.00e-05 | 61 | 16 | 3 | CID000003667 | |
| Drug | lercanidipine | 1.10e-05 | 63 | 16 | 3 | CID000065866 | |
| Drug | succinylcholine | 1.16e-05 | 64 | 16 | 3 | CID000005314 | |
| Drug | fura 2 | 1.21e-05 | 65 | 16 | 3 | CID000057054 | |
| Drug | gallopamil | 1.33e-05 | 67 | 16 | 3 | CID000001234 | |
| Drug | strontium | 1.39e-05 | 68 | 16 | 3 | CID000104798 | |
| Drug | tBuBHQ | 1.45e-05 | 69 | 16 | 3 | CID000002374 | |
| Drug | AC1L2AC7 | 1.45e-05 | 69 | 16 | 3 | CID000068733 | |
| Drug | flecainide | 1.58e-05 | 71 | 16 | 3 | CID000003355 | |
| Drug | AC1L1D8L | 1.58e-05 | 71 | 16 | 3 | CID000002241 | |
| Drug | FLA 365 | 1.66e-05 | 9 | 16 | 2 | CID000072776 | |
| Drug | lactosyl lysosphingolipid | 1.66e-05 | 9 | 16 | 2 | CID006439268 | |
| Drug | CAS 298-57-7 | 1.72e-05 | 73 | 16 | 3 | CID000002761 | |
| Drug | ethosuximide | 1.79e-05 | 74 | 16 | 3 | CID000003291 | |
| Drug | AC1N38XE | 2.08e-05 | 10 | 16 | 2 | CID004060965 | |
| Drug | nisoldipine | 2.10e-05 | 78 | 16 | 3 | CID000004499 | |
| Drug | Fura-2AM | 2.18e-05 | 79 | 16 | 3 | CID000105091 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.18e-05 | 79 | 16 | 3 | CID005287890 | |
| Drug | cADPR | 2.44e-05 | 82 | 16 | 3 | CID000123847 | |
| Drug | 2,3,6,2',3',6'-hexachlorobiphenyl | 2.54e-05 | 11 | 16 | 2 | ctd:C010498 | |
| Drug | tectoridin | 2.54e-05 | 11 | 16 | 2 | CID005281810 | |
| Drug | XeC compound | 2.62e-05 | 84 | 16 | 3 | CID000005701 | |
| Drug | europium | 2.91e-05 | 87 | 16 | 3 | CID000023981 | |
| Drug | tetracaine | 3.01e-05 | 88 | 16 | 3 | CID000005411 | |
| Drug | adenosine diphosphoribose | 3.44e-05 | 92 | 16 | 3 | CID000030243 | |
| Drug | NSC299933 | 3.60e-05 | 13 | 16 | 2 | CID000431902 | |
| Drug | ruthenium | 3.67e-05 | 94 | 16 | 3 | CID000023950 | |
| Drug | manidipine | 3.79e-05 | 95 | 16 | 3 | CID000004008 | |
| Drug | isotetrandrine | 4.03e-05 | 97 | 16 | 3 | CID000005422 | |
| Drug | borate | 4.16e-05 | 98 | 16 | 3 | CID000007628 | |
| Drug | nitrendipine | 4.16e-05 | 98 | 16 | 3 | CID000004507 | |
| Drug | bimoclomol | 4.19e-05 | 14 | 16 | 2 | CID009576891 | |
| Drug | NP-EGTA | 4.19e-05 | 14 | 16 | 2 | CID000183793 | |
| Drug | indo-1 | 4.29e-05 | 99 | 16 | 3 | CID000105060 | |
| Drug | isradipine | 4.42e-05 | 100 | 16 | 3 | CID000003784 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.31e-10 | 3 | 16 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.31e-10 | 3 | 16 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.16e-06 | 195 | 16 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.05e-05 | 80 | 16 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | susceptibility to rheumatic fever measurement | 1.03e-04 | 28 | 16 | 2 | EFO_0008416 | |
| Disease | acute lymphoblastic leukemia | 5.79e-04 | 66 | 16 | 2 | EFO_0000220 | |
| Disease | Intellectual Disability | 1.67e-03 | 447 | 16 | 3 | C3714756 | |
| Disease | ascending aortic diameter | 2.57e-03 | 140 | 16 | 2 | EFO_0021787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMDELTPEQYKMCMQ | 481 | Q8TDX6 | |
| FSKFSLDCPSCDMME | 366 | Q8IX12 | |
| MKETFCMSSMKCYRS | 341 | Q15760 | |
| AQCMFFKDKTMLCPM | 4491 | Q8NEZ4 | |
| CEEYGIMCPMEEVMS | 256 | Q8N573 | |
| EEMMFCDMCDRGYHT | 446 | Q8WUB8 | |
| MCTKEMEFKCMLFAL | 4016 | Q9UFH2 | |
| DMLCALMCPMHDDYD | 476 | O75165 | |
| YDGFMASMDMKTCID | 1311 | P35556 | |
| LYSLPKLTCMCCMFM | 151 | Q96Q07 | |
| DEPDMKCDDMMTCYL | 4871 | P21817 | |
| KCDDMMTCYLFHMYV | 4876 | P21817 | |
| TPDMKCDDMLTCYMF | 4801 | Q92736 | |
| AEMPLFKLYMVMSAC | 256 | Q9NPR9 | |
| DMKCDDMMTCYLFHM | 4706 | Q15413 | |
| MEGDCLSCMKYLMFV | 1 | Q96SJ8 | |
| YMSDQEEDMCFEGMK | 531 | Q6PJT7 |